Ovid Therapeutics Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Ovid Therapeutics Inc. (OVID) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 2.37 million shares for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-13.
Discontinued
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2023-03-13
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2018-03-31 was 16.63K shares, a 88.08% decline year-over-year.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-12-31 was 22.45K shares.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-09-30 was 60.97K shares.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2017-06-30 was 0.00 shares.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 2.37M shares, a 70.92% increase from fiscal 2021.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 1.38M shares, a 233.08% increase from fiscal 2020.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 415.53K shares, a 51.49% decline from fiscal 2019.
- Ovid Therapeutics Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 856.60K shares, a 15.13% decline from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2022-12-31 | 2.37M shares 10-K · filed 2023-03-13 | |||
| 2021-12-31 | 1.38M shares 10-K · filed 2023-03-13 | |||
| 2020-12-31 | 415.53K shares 10-K · filed 2022-03-15 | |||
| 2019-12-31 | 856.60K shares 10-K · filed 2021-03-15 | |||
| 2018-12-31 | 1.01M shares 10-K · filed 2020-03-11 | |||
| 2018-03-31 | 16.63K shares 10-Q · filed 2018-05-08 | 39.08K shares derived: sum of 2 quarters · filed 2019-03-07 | 100.05K shares derived: sum of 3 quarters · filed 2019-03-07 | 100.05K shares derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-12-31 | 22.45K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | 83.42K shares derived: sum of 2 quarters · filed 2019-03-07 | 83.42K shares derived: sum of 3 quarters · filed 2019-03-07 | 222.95K shares 10-K · filed 2019-03-07 |
| 2017-09-30 | 60.97K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 60.97K shares derived: sum of 2 quarters · filed 2017-11-09 | 200.50K shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | 139.53K shares 10-Q · filed 2017-08-10 | ||
| 2017-03-31 | 139.53K shares 10-Q · filed 2017-06-13 | |||
| 2016-12-31 | 260.46K shares 10-K · filed 2018-03-29 | |||
| 2015-12-31 | 0.00 shares 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |